Literature DB >> 9226845

Clinical manifestations, diagnosis, treatment, and prevention of Rhodococcus equi infections in foals.

S Giguère1, J F Prescott.   

Abstract

Since the 1986 Rhodococcus equi workshop, there have been major breakthroughs in understanding the epidemiology of, the virulence of, and the immune response to, this intriguing pathogen. However, with the exception of the use of hyperimmune plasma for the prevention of the disease (Martens et al., 1989; Madigan et al., 1991) the clinical aspects of R. equi infections have essentially remained unchanged. This article reviews the various clinical manifestations and summarizes recent advances in diagnosis, treatment and prevention of R. equi infections in foals.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9226845     DOI: 10.1016/s0378-1135(97)00099-0

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  37 in total

1.  Effects of location for collection of air samples on a farm and time of day of sample collection on airborne concentrations of virulent Rhodococcus equi at two horse breeding farms.

Authors:  Kyle R Kuskie; Jacqueline L Smith; Naisyin Wang; Craig N Carter; M Keith Chaffin; Nathan M Slovis; Randolph S Stepusin; Anthony E Cattoi; Shinji Takai; Noah D Cohen
Journal:  Am J Vet Res       Date:  2011-01       Impact factor: 1.156

2.  Internally controlled real-time PCR method for quantitative species-specific detection and vapA genotyping of Rhodococcus equi.

Authors:  David Rodríguez-Lázaro; Deborah A Lewis; Alain A Ocampo-Sosa; Ursula Fogarty; László Makrai; Jesús Navas; Mariela Scortti; Marta Hernández; José A Vázquez-Boland
Journal:  Appl Environ Microbiol       Date:  2006-06       Impact factor: 4.792

3.  MICs of oxazolidinones for Rhodococcus equi strains isolated from humans and animals.

Authors:  T L Bowersock; S A Salmon; E S Portis; J F Prescott; D A Robison; C W Ford; J L Watts
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

4.  Phenotypic mutants of the intracellular actinomycete Rhodococcus equi created by in vivo Himar1 transposon mutagenesis.

Authors:  Joseph Ashour; Mary K Hondalus
Journal:  J Bacteriol       Date:  2003-04       Impact factor: 3.490

5.  Performance of five serological assays for diagnosis of Rhodococcus equi pneumonia in foals.

Authors:  Steeve Giguère; Jorge Hernandez; Jack Gaskin; John F Prescott; Shinji Takai; Corey Miller
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

6.  Identification of Mycobacterium species and Rhodococcus equi in peccary lymph nodes.

Authors:  Amanda Bonalume Cordeiro de Morais; Carmen Alicia Daza Bolaños; Ana Carolina Alves; Cássia Yumi Ikuta; Gustavo Henrique Batista Lara; Marcos Bryan Heinemann; Rogério Giuffrida; Fernando Paganini Listoni; Mateus de Souza Ribeiro Mioni; Rodrigo Garcia Motta; Shinji Takai; Márcio Garcia Ribeiro
Journal:  Trop Anim Health Prod       Date:  2018-03-15       Impact factor: 1.559

7.  Rhodococcus equi pleuropneumonia in an adult horse.

Authors:  Modest Vengust; Henry Staempfli; John F Prescott
Journal:  Can Vet J       Date:  2002-09       Impact factor: 1.008

8.  Detection of virulent Rhodococcus equi in exhaled air samples from naturally infected foals.

Authors:  G Muscatello; J R Gilkerson; G F Browning
Journal:  J Clin Microbiol       Date:  2009-01-14       Impact factor: 5.948

9.  Rapid identification of Rhodococcus equi by a PCR assay targeting the choE gene.

Authors:  Néstor Ladrón; Marta Fernández; Jesús Agüero; Bruno González Zörn; José A Vázquez-Boland; Jesús Navas
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

10.  Vaccination of mice with salmonella expressing VapA: mucosal and systemic Th1 responses provide protection against Rhodococcus equi infection.

Authors:  Aline F Oliveira; Luciana P Ruas; Silvia A Cardoso; Sandro G Soares; Maria-Cristina Roque-Barreira
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.